SCHEMBL20331733

SCHEMBL20331733

CCOc1cc(OC)cc(-c2cc3cnc(Cl)nc3cn2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.51
▸ RAB9A P51151 6/20 0.51
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP1A1 P04798 3/20 0.42
▸ CYP1B1 Q16678 3/20 0.42
▸ CASP3 P42574 2/20 0.40
▸ SENP7 Q9BQF6 2/20 0.40
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2E1 P05181 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP4B1 P13584 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20330972 0.92 NPC1 (0.59) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL29428742 0.92 NPC1 (0.59) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL18612966 0.82 CYP11B1 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL24335187 0.80 KDM4E (0.56) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL24336038 0.79 FGFR1 (0.46) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL24335312 0.75 CYP11B1 (0.44) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL23315002 0.73 CYP1A2 (0.53) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL20331057 0.73 NPC1 (0.69) NPC1RAB9ACYP1A1CYP1B1CASP3
SCHEMBL29577802 0.73 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL20332207 0.73 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-B1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2022-06-08 — — EP disclosed
WO-2018113584-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 上海和誉生物医药科技有限公司 2018-06-28 — — WO disclosed
Send feedback